| Literature DB >> 20504321 |
Shuqi Xiao1, Qiwei Wang, Jianyu Jia, Peiqing Cong, Delin Mo, Xiangchun Yu, Limei Qin, Anning Li, Yuna Niu, Kongju Zhu, Xiaoying Wang, Xiaohong Liu, Yaosheng Chen.
Abstract
BACKGROUND: Porcine reproductive and respiratory syndrome with PRRS virus (PRRSV) infection, which causes significant economic losses annually, is one of the most economically important diseases affecting swine industry worldwide. In 2006 and 2007, a large-scale outbreak of highly pathogenic porcine reproductive and respiratory syndrome (PRRS) happened in China and Vietnam. However little data is available on global host response to PRRSV infection at the protein level, and similar approaches looking at mRNA is problematic since mRNA levels do not necessarily predict protein levels. In order to improve the knowledge of host response and viral pathogenesis of highly virulent Chinese-type PRRSV (H-PRRSV) and Non-high-pathogenic North American-type PRRSV strains (N-PRRSV), we analyzed the protein expression changes of H-PRRSV and N-PRRSV infected lungs compared with those of uninfected negative control, and identified a series of proteins related to host response and viral pathogenesis.Entities:
Mesh:
Substances:
Year: 2010 PMID: 20504321 PMCID: PMC2887434 DOI: 10.1186/1743-422X-7-107
Source DB: PubMed Journal: Virol J ISSN: 1743-422X Impact factor: 4.099
Figure 1Identification of lungs infected with H-PRRSV and N-PRRSV. Lungs of uninfected negative control and experimentally infected pigs were processed routinely for haematoxylin and eosin (H&E) staining and were re-isolated of H-PRRSV and N-PRRSV viruses and then were identified by IFA and EM. Histopathology examination showed an interstitial pneumonia and emphysema in the lungs with thickening of the alveolar septa accompanied with infiltration of mononuclear cells from both H-PRRSV affected pigs and N-PRRSV affected pigs compared to the lungs of negative control pigs. Viral re-isolates were successfully recovered from lungs of the infected pigs, but not from those of uninfected negative control pigs. Specific immunofluorescence and PRRSV particles in MARC-145 cells infected with re-isolated either H-PRRSV or N-PRRSV was observed by IFA and EM, respectively, but not from those of uninfected negative control group. a. Representative images of HE stained lungs sections from H-PRRSV infected(C), N-PRRSV infected(E), and uninfected negative control (A), original magnifications: ×40.; b. Assessment of H-PRRSV(B) or N-PRRSV(C) re-isolated infected MARC-145 cells or negative control(A) by IFA staining at 48 h; c. H-PRRSV particle(A) and N-PRRSV particle(B) under the electron microscopy (EM).
Figure 2A representative 2D-DIGE picture of an overlay of three dye scan. Proteins were extracted as described and separated in pH 3-10 of 13 cm IPG strips for the first dimension and 12.5% acrylamide for the second dimension. Image was acquired on a Typhoon 9400 scanner. Dots represent spots detected by Decyder software. Cy2 (blue) image of proteins from an internal standard is the pool of all the samples, Cy3 (green) image of proteins from control1, and Cy5 (red) image of proteins from H168_2.
Different expression of proteins between H-PRRSV (H96, H168) inoculated lungs and control identified by MALDI-TOF or MALDI-TOF/TOF.
| Master no.a | Accession no.b | Human protein (Abbr.) | p Valuec | Mr (Da) | pI | Protein scored | Sequence Coverage (%)e |
|---|---|---|---|---|---|---|---|
| 187 | gi|134085736 | ARHGAP29 | 0.0044 | 107466 | 5.65 | 69 | 13 |
| 342 | gi|136192 | TF | 0.0047 | 78971 | 6.93 | 71 | 15 |
| 352 | gi|74005206 | NDUFS1 | 0.0045 | 81056 | 6.1 | 71 | 15 |
| 371 | gi|126309857 | HSPA8 | 0.0055 | 54213 | 5.74 | 97 | 25 |
| 381 | gi|194037328 | KRT79 | 0.0087 | 48266 | 6.07 | 67 | 18 |
| 467 | gi|68317041 | STIP1 | 0.0029 | 32224 | 8.86 | 106 | 58 |
| 507 | gi|231467 | AHSG | 0.0036 | 39199 | 5.5 | 73 | 10 |
| 552 | gi|82822840 | DPYSL2 | 0.0018 | 31025 | 8.07 | 84 | 11 |
| 690 | gi|2724046 | ACTG1 | 0.00037 | 36099 | 5.65 | 112 | 10 |
| 882 | gi|27807289 | ANXA2 | 0.0089 | 38873 | 6.92 | 73 | 6 |
| 885 | gi|23706161 | IDH3A | 0.0014 | 27981 | 9.62 | 165 | 15 |
| 1461 | gi|809283 + gi|1709082 | HBB | 0.0031 | 16082 + 19200 | 6.76 + 6.37 | 102 + 70 | 60 + 43 |
a) Master no. is the unique sample spot protein number.
b) Accession is the MASCOT result of MALDI-TOF/TOF searched from the NCBI nr database.
c) The p value of ONE-ANOVA, p < 0.01, or Independent Student's t-test contrast, p < 0.05.
d) Protein score (based on combined MS and MS/MS spectra) and best ion score (based on MS/MS spectra) were from MALDI-TOF/TOF identification.
e) Sequence coverage (%) is the number of amino acids spanned by the assigned peptides divided by the sequence length.
Different expression of proteins between N-PRRSV (N96, N168) inoculated lungs and control identified by MALDI-TOF or MALDI-TOF/TOF.
| Master no.a | Accession no.b | Human protein (Abbr.) | p Valuec | Mr(Da) | pI | Protein scored | Sequence Coverage (%)e |
|---|---|---|---|---|---|---|---|
| 242 | gi|74008809 | FLNA | 0.0025 | 283130 | 5.74 | 123 | 1 |
| 316 | gi|5821963 | ACO2 | 0.0088 | 83137 | 7.69 | 110 | 3 |
| 481 | gi|66352015 | LMNA | 0.0021 | 65189 | 6.4 | 89 | 30 |
| 612 | gi|194674843 | NTF4 | 0.00044 | 33968 | 9.06 | 72 | 27 |
| 614 | gi|2624886 | ALDH2 | 0.0045 | 54859 | 6.05 | 147 | 6 |
| 616 | gi|40426087 | LAP3 | 0.0063 | 31073 | 5.64 | 193 | 14 |
| 638 | gi|47685624 | ALDH9A1 | 0.0097 | 26192 | 5.43 | 125 | 16 |
| 656 | gi|190360675 | FLOT1 | 0.0089 | 47554 | 7.66 | 74 | 27 |
| 666 | gi|126335980 | CCDC13 | 0.0084 | 83367 | 7.68 | 69 | 19 |
| 938 | gi|194033965 | ANXA1 | 0.0076 | 35689 | 7.16 | 75 | 29 |
| 1016 | gi|149409809 | FECH | 0.0033 | 49485 | 8.48 | 66 | 20 |
| 1038 | gi|87217590 | DDAH2 | 0.0049 | 23244 | 5.33 | 88 | 39 |
| 1173 | gi|50916342 | HSPB1 | 0.00092 | 14268 | 5.94 | 73 | 43 |
| 1200 | gi|544445 | GSTP1 | 0.0036 | 23710 | 8.07 | 166 | 13 |
| 1250 | gi|17892411 | PEBP1 | 0.0019 | 17055 | 5.74 | 149 | 22 |
| 1312 | gi|543113 | TAGLN | 0.0039 | 19326 | 6.96 | 61 | 11 |
| 1316 | gi|5031635 | CFL1 | 0.0093 | 18719 | 8.22 | 43 | 6 |
| 1491 | gi|21545648 | COX5A | 0.0026 | 19379 | 6.88 | 82 | 14 |
a) Master no. is the unique sample spot protein number.
b) Accession is the MASCOT result of MALDI-TOF/TOF searched from the NCBI nr database.
c) The p value of ONE-ANOVA, p < 0.01, or Independent Student's t-test contrast, p < 0.05.
d) Protein score (based on combined MS and MS/MS spectra) and best ion score (based on MS/MS spectra) were from MALDI-TOF/TOF identification.
e) Sequence coverage (%) is the number of amino acids spanned by the assigned peptides divided by the sequence length.
Different expression of proteins between H-PRRSV and N-PRRSV (N96/H96, H168/H168) inoculated lungs identified by MALDI-TOF or MALDI-TOF/TOF.
| Master no.a | Accession no.b | Human protein (Abbr) | Average ratiof | Protein scored | Sequence Coveragee (%) | |||
|---|---|---|---|---|---|---|---|---|
| N96/H96 | ||||||||
| 484 | gi|66352015 | LMNA | -3.14 | 0.0075 | 65189 | 6.4 | 76 | 36 |
| 1173 | gi|50916342 | HSPB1 | -2.35 | 0.00063 | 14268 | 5.94 | 73 | 43 |
| 477 | gi|61867592 | STIP1 | -2.19 | 0.033 | 63056 | 6.02 | 41 | 1 |
| 604 | gi|410689 | LAP3 | -2.01 | 0.0092 | 55996 | 5.68 | 66 | 6 |
| 481 | gi|66352015 | LMNA | -1.99 | 0.012 | 65189 | 6.4 | 89 | 30 |
| 374 | gi|27806351 | EZR | -1.92 | 0.035 | 68832 | 6.06 | 70 | 1 |
| 460 | gi|66352015 | LMNA | -1.83 | 0.035 | 65189 | 6.4 | 68 | 26 |
| 1303 | gi|40423533 | AP3S2 | -1.77 | 0.034 | 29516 | 11.16 | 100 | 37 |
| 1415 | gi|15082144 | SOD1 | -1.66 | 0.047 | 15408 | 6.04 | 78 | 21 |
| 1312 | gi|543113 | TAGLN | -1.6 | 0.04 | 19326 | 6.96 | 61 | 11 |
| 520 | Gi|194034593 | KIAA1468 | -1.58 | 0.00093 | 120185 | 5.38 | 70 | 9 |
| 848 | gi|37800811 | GPD1L | -1.55 | 0.029 | 22781 | 5.4 | 90 | 46 |
| 1292 | gi|182851479 | VIM | 1.6 | 0.011 | 18149 | 4.7 | 137 | 72 |
| 921 | gi|54020966 | ANXA2 | 1.63 | 0.045 | 38795 | 6.49 | 52 | 7 |
| 942 | gi|148747594 | RPLP0 | 1.63 | 0.026 | 34508 | 5.71 | 159 | 18 |
| 616 | gi|40426087 | LAP3 | 1.74 | 0.0073 | 31073 | 5.64 | 193 | 14 |
| 1428 | gi|89886167 | FABP5 | 1.82 | 0.018 | 15485 | 6.6 | 100 | 31 |
| N168/H168 | ||||||||
| 1235 | gi|959814 | FUT1 | -1.59 | 0.02 | 15873 | 9.52 | 184 | 35 |
| 1171 | gi|27806479 | PKP1 | 1.7 | 0.008 | 81498 | 9.18 | 68 | 17 |
| 1519 | gi|6843240 | HBA2 | 2.09 | 0.00028 | 13025 | 8.81 | 182 | 25 |
| 1506 | gi|6843240 | HBA2 | 2.21 | 0.01 | 13025 | 8.81 | 220 | 30 |
a) Master no. is the unique sample spot protein number.
b) Accession is the MASCOT result of MALDI-TOF/TOF searched from the NCBI nr database.
c) The p value of ONE-ANOVA, p < 0.01, or Independent Student's t-test contrast, p < 0.05.
d) Protein score (based on combined MS and MS/MS spectra) and best ion score (based on MS/MS spectra) were from MALDI-TOF/TOF identification.
e) Sequence coverage (%) is the number of amino acids spanned by the assigned peptides divided by the sequence length.
f) Average ratios were calculated considering 6 replica gels and were calculated using Decyder software as the fold -change between normalized spot volume between N-PRRSV-infected lungs (N96 or N168) and H-PRRSV-infected lungs (H96 or H168) homogenates (Independent Student's t-test was based on the log of the ratio between N96 and H96, or between N168 and H168).
Figure 3Graph of the protein interaction network of identified proteins. The protein interaction network was constructed from the identified proteins according their properties and expression level in differential samples. A) graph of the protein interaction network from identified proteins of H-PRRSV-infected lungs, HSP70, NDUFS1,and GMIP show the highest degree (7) belonging to the most central protein, therefore they might be of great importance to the protein-protein interaction network; B) graph of the protein interaction network from identified proteins of N-PRRSV-infected lungs, DDAH2 with the highest degree (10) followed by another two proteins (HSP27(HSPB1) and FLNA) with degree(8), tend to be more essential than non-central proteins in modular organization of the protein-protein interaction network.
Figure 4Expression analyses of selected proteins using DeCyder software and western blot validation. A) Representative 2D-DIGE image, quantification, and western blot confirmation of TF in H-PRRSV infected pigs. The standard abundance of the different spots (y-axis) is also shown for the three different experimental conditions: A (control), B (H96), C (H168) (x-axis). Equal amounts of total protein, as shown for GAPDH, were loaded for Western blotting analysis; B) Representative 2D-DIGE image, quantification, and western blot confirmation of HSPB1 in N-PRRSV infected pigs and those between N-PRRSV vs. H-PRRSV. The standard abundance of the different spots (y-axis) is also shown for different experimental conditions: A (control), D (N96), E (N168), B (H96) (x-axis). Equal amounts of total protein, as shown for GAPDH, were loaded for Western blotting analysis.
Figure 5Immunohistochemistry validation of HSPB1. The expression pattern of HSPB1 in lungs infected with H-PRRSV and N-PRRSV was investigated by immunohistochemistry. Uninfected negative control lungs, lungs infected with H-PRRSV (H96 and H168), and lungs infected with N-PRRSV (N96 and N168) were stained with anti-HSP27 antibodies. Original magnifications: ×40.
2D-DIGE experimental design*.
| Gel | Cy2(blue) | Cy3(green) | Cy5(red) |
|---|---|---|---|
| 1 | pool | A1 (Control1) | C2 (H168_2) |
| 2 | pool | C1 (H168_1) | E3 (N168_3) |
| 3 | pool | D2 (N96_2) | B2 (H96_2) |
| 4 | pool | B1 (H96_1) | E2 (N168_2) |
| 5 | pool | E1 (N168_1) | A1 (Control1) |
| 6 | pool | D3 (N96_3) | C3 (H168_3) |
| 7 | pool | B3 (H96_3) | A2 (Control2) |
| 8 | pool | A3 (Control3) | D1 (N96_1) |
*Control and experimental samples (H96, H168, N96, N168) were labeled with either Cy3 or Cy5. Equal amounts of protein lysates from 3 uninfected negative control and 12 experimental samples were pooled as the internal standard, and labeled with Cy2. Each gel was loaded with 50 μg of Cy2-labeled protein pool, 50 μg of Cy3-labeled and 50 μg of Cy5-labeled samples as indicated. Three replicates were used by each experimental condition.